Mirae Asset Global Investments Co., Ltd. Dyne Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,785 shares of DYN stock, worth $53,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,785
Previous 3,391
11.62%
Holding current value
$53,860
Previous $79,000
50.63%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$147 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$138 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$130 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$105 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$105 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $737M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...